Predictors of relapse after omalizumab withdrawal in chronic spontaneous urticaria: Role of baseline autoimmunity and hematologic indices: CSU Relapse After Omalizumab Withdrawal
{{output}}
Background: There is currently no accepted biomarker for predicting which patients will experience relapse after discontinuation of omalizumab therapy. Objective: This retrospective study aimed to identify clinical and laboratory markers associated with chroni... ...
